Recent Updates
Recently added Catalysts
NVAX Positive Sentiment

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Key Takeaway: Novavax, Inc. has announced its participation in the 2026 Jefferies Global Healthcare Conference. The event will feature a fireside chat, with a webcast available for 30 days on the company's website. This participation highlights Novavax's commitment to addressing global health challenges through its innovative vaccine technologies.
Price reaction · baseline $10.51 (2026-06-01 close) · hit pre-market · clean, no other NVAX news in the window
day 0 close · peak
-2.9%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a significant healthcare conference
  • Opportunity to showcase scientific expertise
  • Engagement with investors and stakeholders

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
SARS-CoV-2 rS/Matrix-M1 Adjuvant
Phase 3 · SARS-CoV-2 Infection

Full Press Release Details

GAITHERSBURG, Md.,June 1, 2026/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.
Conference Details:
Fireside Chat
Date: Thursday, June 4, 2026
Time: 10:30 – 11:00 a.m. Eastern Time
Location: New York, NY
RecordingsA webcast of the fireside chat will be available on the Events & Presentations page of the Company's website atir.novavax.com. A replay of the webcast will be available for 30 days.
About NovavaxNovavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M®adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid, R21/Matrix-M™), Matrix technology and R&D assets. Please visitnovavax.comandLinkedInfor more information.

Frequently Asked Questions

What is the 2026 Jefferies Global Healthcare Conference?

It is a significant event where healthcare companies showcase their innovations and engage with investors.

How can I access the Novavax webcast?

The webcast will be available on Novavax's Events & Presentations page for 30 days.

What technologies does Novavax focus on?

Novavax specializes in vaccines, utilizing its Matrix-M adjuvant and protein-based nanoparticles.

Who can I contact for investor inquiries at Novavax?

Investors can contact Jim Kelly at 844-668-2829 or via email.

Last updated: Jun 2, 2026